Open-Angle Glaucoma Market to Register Incremental Growth During the Forecast Period 2032, Asserts DelveInsight | Key Companies – GrayBug, Annexon, PolyActiva, Aerpio, SALVAT, Qlaris Bio, Nicox

 Breaking News
  • No posts were found

Open-Angle Glaucoma Market to Register Incremental Growth During the Forecast Period 2032, Asserts DelveInsight | Key Companies – GrayBug, Annexon, PolyActiva, Aerpio, SALVAT, Qlaris Bio, Nicox

September 15
00:36 2022
Open-Angle Glaucoma Market to Register Incremental Growth During the Forecast Period 2032, Asserts DelveInsight | Key Companies - GrayBug, Annexon, PolyActiva, Aerpio, SALVAT, Qlaris Bio, Nicox
Delveinsight Business Research LLP
As per DelveInsight’s assessment, globally, there are 20+ companies working on 20+ pipeline drugs in the Open-Angle Glaucoma therapeutics landscape. The Open-Angle Glaucoma market size is expected to increase immensely in the coming years owing to the expected launch of potential therapies and increasing awareness among the general population about the disease.

DelveInsight’s “Open-Angle Glaucoma Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Open-Angle Glaucoma Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Open-Angle Glaucoma market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Open-Angle Glaucoma Market

Open-Angle Glaucoma: An Overview

Glaucoma describes a group of conditions in which there is characteristic cupping of the optic disc with corresponding visual field defects, due to retinal ganglion cell loss. It is a progressive condition and the most common cause of irreversible blindness worldwide. The two major categories of glaucoma are open-angle glaucoma (OAG) and narrow-angle glaucoma.

The OAG is primarily divided into two subtypes, i.e., Primary open-angle glaucoma (POAG) and Secondary open-angle glaucoma. POAG is a subset of glaucoma defined by an open, normal-appearing anterior chamber angle and raised intraocular pressure (IOP), with no other underlying disease. In Secondary open-angle glaucoma, there is an identifiable cause of increased eye pressure, resulting in optic nerve damage and vision loss.

Open-Angle Glaucoma Market Key Facts

  • A recent review estimated the global number of Primary open-angle glaucoma (POAG) cases in 2013 at 44 million, rising to 53 million in 2020 due to population aging.

  • Primary open-angle glaucoma (POAG) is the most common type of glaucoma, accounting for three-quarters (74%) of all glaucoma cases.

  • DelveInsight’s analysts have assessed that the total prevalent population of Glaucoma in the 7MM was around 10 million in 2018. In addition to this, it was also assessed that among those with glaucoma in the 7MM, more than 8.5 million were diagnosed with OAG.

  • According to DelveInsight’s analysis, females are affected more than males in the case of open-Angle  Glaucoma.

Open-Angle Glaucoma Market

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Open-Angle Glaucoma market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report details the Open-Angle Glaucoma market trend for each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.

Open-Angle Glaucoma Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.

Open-Angle Glaucoma Epidemiology Segmentation

  • Total Diagnosed Prevalent Population of Open-Angle Glaucoma

  • Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma

  • Gender-Specific Diagnosed Prevalence of Open-Angle Glaucoma 

  • Type-Specific Diagnosed Prevalence of Open-Angle Glaucoma

Open-Angle Glaucoma Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Open-Angle Glaucoma market or expected to get launched during the study period. The analysis covers Open-Angle Glaucoma market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Open-Angle Glaucoma Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report –

Open-Angle Glaucoma Therapeutics Analysis

There are approx. 20+ key companies which are developing therapies for Open-Angle Glaucoma. Currently, Ocular Therapeutix has its drug candidates in the most advanced stage of clinical development.

Some of the key companies in the Open-Angle Glaucoma Market include 

• Allergan

• SPARC Limited

• Laboratorios Sophia 

• Nicox Ophthalmics

• Qlaris Bio

• Ocular Therapeutix


• Aerpio Pharmaceuticals

• Ocularis Pharma

• PolyActiva

• AbbVie

• Annexon

• Skye Bioscience

• GrayBug

• Quark Pharmaceuticals

And many others.

Open-Angle Glaucoma Therapies covered in the report include:

• Durysta (Bimatoprost SR)

• PDP–716

• PRO-122

• DE-130A

• QLS-101

• Razuprotafib

And others.

Get More Detailed Insights Into the Emerging Therapies & Key Companies –

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Open-Angle Glaucoma Competitive Intelligence Analysis

4. Open-Angle Glaucoma Market Overview at a Glance

5. Open-Angle Glaucoma Disease Background and Overview

6. Open-Angle Glaucoma Patient Journey

7. Open-Angle Glaucoma Epidemiology and Patient Population

8. Open-Angle Glaucoma Treatment Algorithm, Current Treatment, and Medical Practices

9. Open-Angle Glaucoma Unmet Needs

10. Key Endpoints of Open-Angle Glaucoma Treatment

11. Open-Angle Glaucoma Marketed Products

12. Open-Angle Glaucoma Emerging Therapies

13. Open-Angle Glaucoma Seven Major Market Analysis

14. Attribute Analysis

15. Open-Angle Glaucoma Market Outlook (7 major markets)

16. Open-Angle Glaucoma Access and Reimbursement Overview

17. KOL Views on the Open-Angle Glaucoma Market.

18. Open-Angle Glaucoma Market Drivers

19. Open-Angle Glaucoma Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report –


About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Other Trending Healthcare Reports by DelveInsight

Primary Progressive Multiple Sclerosis (PPMS) Market
“Primary Progressive Multiple Sclerosis (PPMS) Market” research report provides a detailed overview of the historical and forecasted epidemiology as well as the Primary Progressive Multiple Sclerosis Market size, share, and trends in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan). Additionally, it also covers the latest innovations, breakthroughs, emerging therapies, and key companies operating in the therapeutics market. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States

Related Articles